CHE
Chemed Corporation Healthcare - Medical Care Facilities Investor Relations →
Chemed Corporation (CHE) closed at $422.16 as of 2026-05-01, trading 18.4% below its 200-week moving average of $517.54. This places CHE in the extreme value zone. The stock moved further from the line this week, up from -18.7% last week. The 14-week RSI sits at 45, indicating neutral momentum.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.81 ratio) is neutral — neither side is clearly dominating.
Over the past 2717 weeks of data, CHE has crossed below its 200-week moving average 36 times. On average, these episodes lasted 14 weeks. Historically, investors who bought CHE at the start of these episodes saw an average one-year return of +16.2%.
With a market cap of $5.6 billion, CHE is a mid-cap stock. The company generates a free cash flow yield of 6.2%, which is healthy. Return on equity stands at 25.6%, indicating strong profitability. The stock trades at 6.6x book value.
The company has been aggressively buying back shares, reducing its share count by 7.8% over the past three years. CHE passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 33.3 years, a hypothetical investment of $100 in CHE would have grown to $5499, compared to $2973 for the S&P 500. That represents an annualized return of 12.8% vs 10.7% for the index — confirming CHE as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 8.8% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: CHE vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CHE Crosses Below the Line?
Across 15 historical episodes, buying CHE when it crossed below its 200-week moving average produced an average return of +16.9% after 12 months (median +14.0%), compared to +5.3% for the S&P 500 over the same periods. 79% of those episodes were profitable after one year. After 24 months, the average return was +33.6% vs +10.6% for the index.
Each line shows $100 invested at the moment CHE crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
CHE has crossed below its 200-week MA 36 times with an average 1-year return of +16.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 1974 | Jul 1975 | 65 | 71.7% | -51.1% | +19117.9% |
| Jul 1975 | Jan 1976 | 23 | 27.6% | +24.7% | +23066.8% |
| May 1976 | Jun 1976 | 3 | 3.9% | +37.2% | +21581.8% |
| Oct 1976 | Nov 1976 | 3 | 2.2% | +23.7% | +21039.7% |
| Mar 1982 | Mar 1982 | 1 | 0.2% | +93.1% | +11644.3% |
| Jul 1984 | Jul 1984 | 1 | 0.4% | +13.4% | +7729.5% |
| Sep 1984 | Jan 1985 | 18 | 7.7% | +9.4% | +7839.8% |
| Apr 1985 | Jun 1985 | 8 | 3.4% | +38.1% | +7483.8% |
| Aug 1985 | Aug 1985 | 1 | 0.1% | +13.6% | +7096.5% |
| Sep 1985 | Nov 1985 | 8 | 8.6% | +3.4% | +7158.3% |
| Dec 1985 | Dec 1985 | 1 | 0.3% | +21.8% | +6976.1% |
| Aug 1986 | Aug 1986 | 1 | 0.3% | +36.4% | +6455.0% |
| Sep 1986 | Sep 1986 | 2 | 7.1% | +35.7% | +6691.9% |
| Oct 1986 | Oct 1986 | 1 | 0.5% | +17.8% | +6455.0% |
| Oct 1987 | Dec 1987 | 10 | 16.8% | +9.8% | +6831.1% |
| May 1988 | Sep 1988 | 20 | 11.0% | +6.3% | +6234.0% |
| Oct 1988 | Jan 1989 | 13 | 10.9% | +12.9% | +6210.4% |
| Jan 1989 | Feb 1989 | 2 | 2.1% | +3.7% | +6168.2% |
| Mar 1989 | Mar 1989 | 1 | 0.8% | +0.2% | +6105.4% |
| Jan 1990 | Feb 1990 | 1 | 2.2% | -39.5% | +5944.5% |
| Mar 1990 | Nov 1991 | 88 | 41.2% | -21.6% | +6092.5% |
| Jul 1998 | Nov 1998 | 19 | 21.1% | +7.1% | +3322.2% |
| Jan 1999 | May 1999 | 16 | 18.7% | +4.6% | +3387.9% |
| May 1999 | Jun 1999 | 2 | 0.6% | +1.6% | +3233.6% |
| Aug 1999 | May 2000 | 41 | 20.6% | +1.4% | +3300.5% |
| Jun 2000 | Sep 2000 | 12 | 7.7% | +17.0% | +3390.6% |
| Jul 2001 | Aug 2001 | 2 | 10.4% | +22.6% | +3510.1% |
| Aug 2001 | Nov 2001 | 13 | 12.1% | +14.2% | +3247.6% |
| Jul 2002 | Jul 2002 | 1 | 2.3% | +27.0% | +3179.4% |
| Sep 2002 | Sep 2002 | 1 | 0.5% | +24.4% | +3092.2% |
| Oct 2002 | Oct 2002 | 1 | 1.4% | +25.6% | +3123.6% |
| Sep 2006 | Oct 2006 | 1 | 0.3% | +93.6% | +1371.3% |
| Mar 2008 | Oct 2009 | 83 | 30.3% | -13.0% | +984.4% |
| Oct 2009 | Nov 2009 | 5 | 2.2% | +31.3% | +929.4% |
| Sep 2022 | Oct 2022 | 4 | 2.8% | +19.4% | -2.1% |
| Jun 2025 | Ongoing | 44+ | 29.0% | Ongoing | -10.4% |
| Average | 14 | — | +16.2% | — |
Frequently Asked Questions
Is CHE below its 200-week moving average?
Yes. As of 2026-05-01, Chemed Corporation (CHE) is trading 18.4% below its 200-week moving average of $517.54. The current price is $422.16.
What is CHE's 200-week moving average price?
Chemed Corporation's 200-week moving average is $517.54 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when CHE drops below its 200-week moving average?
CHE has crossed below its 200-week moving average 36 times in our data. On average, buying at that moment produced a one-year return of +16.2%. These dips have historically been decent entry points. These episodes lasted 14 weeks on average.
Is CHE a good value right now?
Here's what our data says about CHE as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 45. Free cash flow yield is 6.2%. Return on equity is 25.6%. Price-to-book is 6.6x. This is not a buy or sell recommendation — always do your own research.
How does CHE compare to the S&P 500?
Over the past 33.3 years, $100 invested in CHE would have grown to $5499, compared to $2973 for the S&P 500. That's 12.8% annualized vs 10.7% for the index. CHE has outperformed the broader market over this period.
Does CHE pay a dividend?
Yes. Chemed Corporation currently pays a dividend yield of 54.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01